
# Title 42 - Public Health
## Chapter IV - Centers for Medicare & Medicaid Services, Department of Health and Human Services
### Subchapter B - Medicare Program
#### PART 413 - PRINCIPLES OF REASONABLE COST REIMBURSEMENT; PAYMENT FOR END-STAGE RENAL DISEASE SERVICES; PROSPECTIVELY DETERMINED PAYMENT RATES FOR SKILLED NURSING FACILITIES; PAYMENT FOR ACUTE KIDNEY INJURY DIALYSIS
##### Subpart H - Payment for End-Stage Renal Disease (ESRD) Services
###### ยง 413.234 Drug designation process.
####### physical combination,Type 1 NDA,,1,Type 4 NDA,,Type 2 NDA,,Type 4 NDA,

(B) A newmay be two or more active ingredients combined into a single dosage form, or two or more drugs packaged together with combined labeling. When at least one of the active moieties is classified as an NME, the NDA is classified as a combination of aas described in paragraph (e)(5)(ii)(B)() of this section, with aas described in paragraph (e)(5)(ii) of this section. When none of the active moieties is an NME, but at least one is a new active ingredient, the NDA is classified as a combination of aas described in paragraph (e)(5)(i) of this section, with aas described in paragraph (e)(5)(ii) of this section.
